Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PACLITAXEL INJECTION USP 6 MG

PACLITAXEL : 6 MG · DIN 02391465 · ACCORD HEALTHCARE INC

Health Canada status: MARKETED

What is PACLITAXEL INJECTION USP?

PACLITAXEL INJECTION USP 6 MG contains PACLITAXEL : 6 MG. It is listed in the Health Canada Drug Product Database under DIN 02391465, held by ACCORD HEALTHCARE INC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 02-Jul-2014. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02391465
Brand namePACLITAXEL INJECTION USP
Generic / active ingredientPACLITAXEL : 6 MG
ManufacturerACCORD HEALTHCARE INC
Strength6 MG
Dosage formSOLUTION
Route of administrationINTRAVENOUS
SchedulePrescription
ATC codeL01CD01 PACLITAXEL
AHFS class10:00.00
BiosimilarNo
Health Canada statusMARKETED
Status date02-Jul-2014
Original market date2014-07-02 00:00:00

Is PACLITAXEL in shortage in Canada?

A Canadian shortage report is on file for this molecule: Resolved — reported by ACCORD HEALTHCARE INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for PACLITAXEL INJECTION USP

What can be used instead?

Other Canadian products sharing ATC code L01CD01 PACLITAXEL. 5 of 19 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
ABRAXANE FOR INJECTABLE SUSPENSION100 MGPOWDER FOR SUSPENSIONBRISTOL-MYERS SQUIBB CANADAMARKETEDDIN 02281066
PACLITAXEL FOR INJECTION6 MGSOLUTIONBIOLYSE PHARMA CORPORATIONMARKETEDDIN 02244372
PACLITAXEL INJECTION USP6 MGSOLUTIONSANDOZ CANADA INCORPORATEDMARKETEDDIN 02320150
PACLITAXEL POWDER FOR INJECTABLE SUSPENSION NANOPARTICLE, ALBUMIN-BOUND PACLITAXEL100 MGPOWDER FOR SUSPENSIONPANACEA BIOTEC PHARMA LIMITEDMARKETEDDIN 02496097
AJ-PACLITAXEL6 MGSOLUTIONAGILA JAMP CANADA INCCANCELLED PRE MARKETDIN 02409712
APO-PACLITAXEL INJECTABLE6 MGSOLUTIONAPOTEX INCDORMANTDIN 02248844
PACLITAXEL6 MGLIQUIDIVAX PHARMACEUTICALS INCORPORATEDCANCELLED PRE MARKETDIN 02241314
PACLITAXEL FOR INJECTION6 MGSOLUTIONTEVA CANADA LIMITEDAPPROVEDDIN 02285363
PACLITAXEL FOR INJECTION6 MGSOLUTIONPFIZER CANADA ULCCANCELLED POST MARKETDIN 02296624
PACLITAXEL FOR INJECTION USP6 MGSOLUTIONSTERIMAX INCDORMANTDIN 02320010

Who else supplies PACLITAXEL worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. PACLITAXEL appears in 289 registered pack listings across 11 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for PACLITAXEL INJECTION USP

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02391465. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.